The decision comes at a crucial juncture in the US's vaccination effort, which has gained speed in recent weeks at the same time a worsening outbreak grips the upper Midwest.
President Joe Biden described the approval as an encouraging development in efforts to end the Covid-19 crisis and said this is exciting news for all US citizens.
If J&J's phase 3 trial report very strong efficacy, it will be the single-shot vaccine that can be stored and transported at refrigerator temperatures unlike Pfizer and Moderna.
More than 90% of participants made immune proteins within 29 days after receiving the shot & all participants formed the antibodies within 57 days, according to the report.
The deal comes after a study showed Johnson & Johnson’s candidate vaccine generated strong antibody response in primates and provided protection with a single dose.
J&J announced in June that it had accelerated vaccine trials with ambitions of launching human studies in mid-July. The company will dose its first patients on 22 July in Belgium.
Like China, India remains a big domestic market, which will continue to attract investment, but the US tariffs will make India unattractive for future investments.
New bill aims to fix key issues with IBC 2016, including delays & patchy implementation, and protect creditors, with window for genuine promoters to retain control of their companies.
Contrary to claims regarding implementation of theaterisation, ThePrint first reported on 17 June 2021 that it will be delayed. Now, ACM Singh bats for different structure.
Putin sees this as a victory. Europeans have decided to deal with Trump on his terms for the sake of the larger Western alliance. We look at the lessons for us in India.
COMMENTS